Patent Pool Expands Remit To COVID-19
As WHO Welcomes Proposal Covering Rights To Tests, Medicines And Vaccines
The Medicines Patent Pool has expanded its mandate to include treatments that will aid the global response to the coronavirus pandemic.
You may also be interested in...
Lupin and non-profit organization TB Alliance have entered into a partnership for a new therapy for highly drug-resistant tuberculosis, pretomanid, to be distributed in 140 countries and territories.
The Medicines Patent Pool and the International Generic and Biosimilar medicines Association have announced separate initiatives with the continued intention to facilitate access to COVID-19 treatments and vaccines, as the global threat from the novel coronavirus pandemic continues.
Also, Neoimmune looks to interleukin therapy for mild therapy while Daiichi Sankyo bets on a mRNA vaccine.